Baburajeev et al. BMC Cancer (2017) 17:235
Page 13 of 14
with metastatic castrate-resistant prostate cancer. Annals Oncol.
leukemia cell lines by inhibiting histone deacetylases, and inducing p21 and
tubulin acetylation. Bioorg & Medicinal Chem. 2015;23(18):6157–65.
36. Baburajeev CP, Dhananjaya Mohan C, Ananda H, Rangappa S, Fuchs JE,
Jagadish S, Sivaraman Siveen K, Chinnathambi A, Ali Alharbi S, Zayed ME,
et al. Development of Novel Triazolo-Thiadiazoles from Heterogeneous
"Green" Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors. Scientific
Reports. 2015;5:14195.
1
1
9. Dredge K, Hammond E, Handley P, Gonda TJ, Smith MT, Vincent C, Brandt
R, Ferro V, Bytheway I. PG545, a dual heparanase and angiogenesis inhibitor,
induces potent anti-tumour and anti-metastatic efficacy in preclinical
models. Br J Cancer. 2011;104(4):635–42.
2
2
2
2
2
0. Ritchie JP, Ramani VC, Ren Y, Naggi A, Torri G, Casu B, Penco S, Pisano C,
Carminati P, Tortoreto M, et al. SST0001, a chemically modified heparin,
inhibits myeloma growth and angiogenesis via disruption of the
heparanase/syndecan-1 axis. Clin Cancer Res. 2011;17(6):1382–93.
1. Zhou H, Roy S, Cochran E, Zouaoui R, Chu CL, Duffner J, Zhao G, Smith S,
Galcheva-Gargova Z, Karlgren J, et al. M402, a Novel Heparan Sulfate
Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and
Metastasis. PLoS One. 2011;6(6):e21106.
2. Xu Y-J, Miao H-Q, Pan W, Navarro EC, Tonra JR, Mitelman S, Camara MM,
Deevi DS, Kiselyov AS, Kussie P, et al. N-(4-{[4-(1H-Benzoimidazol-2-yl)-
arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule
heparanase inhibitors. Bioorganic & Med Chem Lett. 2006;16(2):404–8.
3. Keerthy HK, Mohan CD, Sivaraman Siveen K, Fuchs JE, Rangappa S,
Sundaram MS, Li F, Girish KS, Sethi G. Basappa et al. Novel synthetic
biscoumarins target tumor necrosis factor-alpha in hepatocellular carcinoma
in vitro and in vivo. J Biol Chem. 2014;289(46):31879–90.
37. Mohan CD, Bharathkumar H, Bulusu KC, Pandey V, Rangappa S, Fuchs JE,
Shanmugam MK, Dai X, Li F, Deivasigamani A, et al. Development of a
novel azaspirane that targets the Janus kinase-signal transducer and
activator of transcription (STAT) pathway in hepatocellular carcinoma
in vitro and in vivo. J Biol Chem. 2014;289(49):34296–307.
38. Basappa M. S, Kavitha CV, Purushothaman A, Nevin KG, Sugahara K,
Rangappa KS. A small oxazine compound as an anti-tumor agent: a novel
pyranoside mimetic that binds to VEGF, HB-EGF, and TNF-alpha. Cancer Lett.
2010;297(2):231–43.
39. Sulaiman NB, Mohan CD, Basappa S, Pandey V, Rangappa S, Bharathkumar
H, Kumar AP, Lobie PE, Rangappa KS. An azaspirane derivative suppresses
growth and induces apoptosis of ER-positive and ER-negative breast cancer
cells through the modulation of JAK2/STAT3 signaling pathway. Int J Oncol.
2016;49(3):1221–9.
40. Hara M, Yoshida T, Takagaki A, Takata T, Kondo JN, Hayashi S, Domen K. A
carbon material as a strong protonic acid. Angew Chem Int Ed.
2004;43(22):2955–8.
41. Toda M, Takagaki A, Okamura M, Kondo JN, Hayashi S, Domen K, Hara M. Green
chemistry: biodiesel made with sugar catalyst. Nature. 2005;438(7065):178.
42. Mo X, López DE, Suwannakarn K, Liu Y, Lotero E, Goodwin JG, Lu C.
Activation and deactivation characteristics of sulfonated carbon catalysts. J
Catalysis. 2008;254(2):332–8.
43. Devi KS, Jayashree S. Modified ceria as a substitute for sulfuric acid in the liquid
phase nitration of toluene. React Kinet Mech Catal. 2013;108(1):183–92.
44. Vlodavsky I, Ilan N, Naggi A, Casu B. Heparanase: structure, biological
functions, and inhibition by heparin-derived mimetics of heparan sulfate.
Curr Pharm Des. 2007;13(20):2057–73.
45. Hulett MD, Hornby JR, Ohms SJ, Zuegg J, Freeman C, Gready JE, Parish CR.
Identification of active-site residues of the pro-metastatic endoglycosidase
heparanase. Biochemistry. 2000;39(51):15659–67.
46. Neelgundmath M, Dinesh KR, Mohan CD, Li F, Dai X, Siveen KS, Paricharak S,
Mason DJ, Fuchs JE, Sethi G, et al. Novel synthetic coumarins that targets
NF-kappaB in Hepatocellular carcinoma. Bioorganic & Med Chem Lett.
2015;25(4):893–7.
47. Anusha S, Anandakumar BS, Mohan CD, Nagabhushana GP, Priya BS,
Rangappa KS. Basappa, T CG. Preparation and use of combustion-derived
Bi2O3 for the synthesis of heterocycles with anti-cancer properties by
Suzuki-coupling reactions. RSC Adv. 2014;4(94):52181–8.
48. Anusha S, Mohan CD, Ananda H, Baburajeev CP, Rangappa S, Mathai J,
Fuchs JE, Li F, Shanmugam MK, Bender A, et al. Adamantyl-tethered-
biphenylic compounds induce apoptosis in cancer cells by targeting Bcl
homologs. Bioorg Med Chem Lett. 2016;26(3):1056–60.
49. Wu L, Viola CM, Brzozowski AM, Davies GJ. Structural characterization of
human heparanase reveals insights into substrate recognition. Nature Struc
Biol. 2015;22(12):1016–22.
50. C. C. G. Molecular Operating Environment version 2014.0901.
51. Zcharia E, Jia J, Zhang X, Baraz L, Lindahl U, Peretz T, Vlodavsky I, Li JP.
Newly generated heparanase knock-out mice unravel co-regulation of
heparanase and matrix metalloproteinases. PLoS One. 2009;4(4):e5181.
52. Fux L, Ilan N, Sanderson RD, Vlodavsky I. Heparanase: busy at the cell
surface. Trends Bioch Sci. 2009;34(10):511–9.
53. Parish CR, Freeman C, Ziolkowski AF, He YQ, Sutcliffe EL, Zafar A, Rao S,
Simeonovic CJ. Unexpected new roles for heparanase in Type 1 diabetes
and immune gene regulation. Matrix Biol. 2013;32(5):228–33.
54. Gil N, Goldberg R, Neuman T, Garsen M, Zcharia E, Rubinstein AM, van
Kuppevelt T, Meirovitz A, Pisano C, Li JP, et al. Heparanase is essential for
the development of diabetic nephropathy in mice. Diabetes.
2012;61(1):208–16.
55. Li RW, Freeman C, Yu D, Hindmarsh EJ, Tymms KE, Parish CR, Smith PN.
Dramatic regulation of heparanase activity and angiogenesis gene
expression in synovium from patients with rheumatoid arthritis. Arthritis &
Rheumatism. 2008;58(6):1590–600.
4. Bharathkumar H, Mohan CD, Ananda H, Fuchs JE, Li F, Rangappa S,
Surender M, Bulusu KC, Girish KS, Sethi G, et al. Microwave-assisted
synthesis, characterization and cytotoxic studies of novel estrogen receptor
alpha ligands towards human breast cancer cells. Bioorganic & Med Chem
Lett. 2015;25(8):1804–7.
2
2
2
2
2
3
5. Rakesh KS, Jagadish S, Vinayaka AC, Hemshekhar M, Paul M, Thushara RM,
Sundaram MS, Swaroop TR, Mohan CD, Basappa, et al. A new ibuprofen
derivative inhibits platelet aggregation and ROS mediated platelet
apoptosis. PloS one. 2014;9(9):107182.
6. Roopashree R, Mohan CD, Swaroop TR, Jagadish S, Raghava B, Balaji KS,
Jayarama S. Basappa, Rangappa KS. Novel synthetic bisbenzimidazole that
targets angiogenesis in Ehrlich ascites carcinoma bearing mice. Bioorganic
&
Med Chem Lett. 2015;25(12):2589–93.
7. Keerthy HK, Garg M, Mohan CD, Madan V, Kanojia D, Shobith R,
Nanjundaswamy S, Mason DJ, Bender A, Basappa, et al. Synthesis and
characterization of novel 2-amino-chromene-nitriles that target Bcl-2 in
acute myeloid leukemia cell lines. PLoS One. 2014;9(9):e107118.
8. Mohan CD, Srinivasa V, Rangappa S, Mervin L, Mohan S, Paricharak S, Baday S,
Li F, Shanmugam MK, Chinnathambi A, et al. Trisubstituted-Imidazoles Induce
Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/
mTOR Signaling Pathway. PLoS One. 2016;11(4):e0153155.
9. Baburajeev CP, Mohan CD, Patil GS, Rangappa S, Pandey V, Sebastian A, Fuchs
JE, Bender A, Lobie PE. Basappa et al. Nano-cuprous oxide catalyzed one-pot
synthesis of a carbazole-based STAT3 inhibitor: a facile approach via
intramolecular C-N bond formation reactions. RSC Adv. 2016;6(43):36775–85.
0. Blich M, Golan A, Arvatz G, Sebbag A, Shafat I, Sabo E, Cohen-Kaplan V,
Petcherski S, Avniel-Polak S, Eitan A, et al. Macrophage activation by
heparanase is mediated by TLR-2 and TLR-4 and associates with plaque
progression. Arteriosclerosis Thromb & Vascular Biol. 2013;33(2):e56–65.
1. Hammond E, Li CP, Ferro V. Development of a colorimetric assay for
heparanase activity suitable for kinetic analysis and inhibitor screening. Anal
Biochem. 2010;396(1):112–6.
3
3
2. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R,
Bitan M, Pappo O, Peretz T, Michal I, et al. Mammalian heparanase: gene
cloning, expression and function in tumor progression and metastasis.
Nature Med. 1999;5(7):793–802.
3
3
3. Vlodavsky I. Preparation of Extracellular Matrices Produced by Cultured
Corneal Endothelial and PF-HR9 Endodermal Cells. Curr protocols Cell Biol.
1999; 10.14. 11-10.14. 14.
4. Bharathkumar H, Mohan CD, Rangappa S, Kang T, Keerthy HK, Fuchs JE,
Kwon NH, Bender A, Kim S. Basappa et al. Screening of quinoline, 1,3-
benzoxazine, and 1,3-oxazine-based small molecules against isolated
methionyl-tRNA synthetase and A549 and HCT116 cancer cells
including an in silico binding mode analysis. Organic & Biomol Chem.
2
015;13(36):9381–7.
3
5. Ashwini N, Garg M, Mohan CD, Fuchs JE, Rangappa S, Anusha S, Swaroop
TR, Rakesh KS, Kanojia D, Madan V, et al. Synthesis of 1,2-benzisoxazole
tethered 1,2,3-triazoles that exhibit anticancer activity in acute myeloid
56. Lerner I, Hermano E, Zcharia E, Rodkin D, Bulvik R, Doviner V, Rubinstein AM,
Ishai-Michaeli R, Atzmon R, Sherman Y, et al. Heparanase powers a chronic